Welcome to our dedicated page for Cognex SEC filings (Ticker: CGNX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking Cognex’s fast-moving machine-vision business through the SEC can feel like hunting for pixels in a high-resolution image—critical details are there, but hidden. Revenue tied to cyclical electronics orders, patent risks around deep-learning algorithms, and the timing of large logistics wins are scattered across hundreds of pages. That complexity is the problem.
Stock Titan’s AI delivers the solution. Our platform pulls every Cognex filing the instant it hits EDGAR, then generates plain-English briefs so you can move from Cognex annual report 10-K simplified to actionable insight in minutes. Want the latest Cognex quarterly earnings report 10-Q filing? We tag segment sales, backlog shifts and margin drivers automatically. Curious about leadership moves? Real-time alerts surface Cognex Form 4 insider transactions real-time and map patterns in Cognex executive stock transactions Form 4.
Here’s what you’ll uncover faster than opening a PDF:
- Form 4 feeds that spotlight insider buys and sells—ideal for monitoring “Cognex insider trading Form 4 transactions.”
- 10-K and 10-Q extracts that answer common searches like “Cognex earnings report filing analysis” and “understanding Cognex SEC documents with AI.”
- 8-K material events explained clearly, from factory fires to major customer wins.
- DEF 14A proxy statement executive compensation breakdowns that reveal how AI innovation shapes bonuses.
No more digging through technical jargon. Whether you’re comparing cap-ex across regions or scanning a Cognex proxy statement executive compensation table, our AI-powered summaries, expert context and one-click downloads let you focus on decisions, not document wrangling.
Sheila Marie DiPalma, Executive Vice President, Employee Services at Cognex Corporation (CGNX), reported open-market dispositions under a Rule 10b5-1 trading plan. On 09/05/2025 she sold 2,002 shares at $45.00, reducing her direct common stock holding to 8,582 shares. On 09/08/2025 she sold 2,000 shares at $45.03, reducing holdings to 6,582 shares. The filing lists substantial outstanding option and restricted stock unit positions exercisable into common stock, totaling tens of thousands of shares across multiple option grants and RSU awards.
Laura A. MacDonald, Vice President and Principal Accounting Officer of Cognex Corporation (CGNX), reported transactions on Form 4 showing an open-market sale and her remaining holdings. On 09/05/2025 she sold 2,666 shares of Cognex common stock at $45 per share pursuant to a Rule 10b5-1 trading plan. After that sale she directly owned 4,593 shares. She also reports 20 shares held by her child, which she disclaims beneficial ownership of except for pecuniary interest.
The filing lists detailed equity compensation holdings: multiple outstanding non-qualified stock options totaling 238,695 underlying shares and restricted stock units totaling 33,914 shares (by schedule), with various exercise prices and expiration dates.
Form 144 notice for Cognex Corp (CGNX): This filing notifies the proposed sale of 4,002 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $177,168.54. The shares represent restricted stock units acquired from the issuer on 02/22/2023 and the filer lists the approximate date of sale as 09/05/2025 on the NASDAQ. The filing reports no securities sold in the past three months for the account and includes the standard signature representation that the seller is not aware of undisclosed material adverse information.
Form 144 notice for Cognex Corp (CGNX) reports a proposed sale of 2,666 shares of Common Stock through broker Robert W Baird & Co., with an aggregate market value of $119,970 and approximate sale date of 09/05/2025 on NASDAQ. The filing shows the 2,666 shares were acquired through three Restricted Stock Unit releases on 02/21/2025, 02/22/2025 and 03/15/2025 totaling 2,666 shares, and fully settled upon vesting. The filing states there were no securities sold in the past three months by the reporting person. Filer contact and issuer identification fields in the notice are present but contain no specific names or CIK values in the provided content.
Matthew Moschner, CEO & President and a director of Cognex Corporation (CGNX), reported equity activity tied to restricted stock units that vested on 08/07/2025. A grant of 3,000 restricted stock units vested on that date, and 881 shares were withheld to satisfy tax-withholding obligations at a reported price of $41.36 per share. The Form 4 shows each RSU converts to one share and explains the vesting schedule for the grant (approximately 20%, 30% and 50% on the first three anniversaries of the grant date). The filing also details the reporting person’s outstanding stock option positions and other RSU balances, including a large option block of 279,070 options at a $27.99 strike, documenting the executive’s continuing equity holdings in the company.
FAQ
What is the current stock price of Cognex (CGNX)?
What is the market cap of Cognex (CGNX)?
